Highly active anti-retroviral therapy and liver mitochondrial toxicity in human immunodeficiency virus / hepatitis C virus co-infection
Background: A third of HIV-infected patients are co-infected with HCV in the developed world, and more of co-infected patients than ever before are dying because of liver related diseases today. Drug-related hepatotoxicity is a growing concern among human immunodeficiency virus (HIV) / hepatitis C v...
| Main Author: | |
|---|---|
| Language: | English |
| Published: |
University of British Columbia
2008
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/2429/2517 |